Innovent Biologics, Inc. (1801.HK)

HKD 36.2

(-0.82%)

Net Income Summary of Innovent Biologics, Inc.

Innovent Biologics, Inc.'s latest annual net income in 2023 was -1.02 Billion CNY , up 52.83% from previous year.
Innovent Biologics, Inc.'s latest quarterly net income in 2024 Q2 was -196.31 Million CNY , down 0.0% from previous quarter.
Innovent Biologics, Inc. reported an annual net income of -2.17 Billion CNY in 2022, up 30.55% from previous year.
Innovent Biologics, Inc. reported an annual net income of -3.13 Billion CNY in 2021, down -214.3% from previous year.
Innovent Biologics, Inc. reported a quarterly net income of -196.31 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Innovent Biologics, Inc. reported a quarterly net income of -444.38 Million CNY for 2023 Q3, down -538.71% from previous quarter.

Annual Net Income Chart of Innovent Biologics, Inc. (2023 - 2016)

Historical Annual Net Income of Innovent Biologics, Inc. (2023 - 2016)

Year	Net Income	Net Income Growth
2023	-1.02 Billion CNY	52.83%
2022	-2.17 Billion CNY	30.55%
2021	-3.13 Billion CNY	-214.3%
2020	-998.42 Million CNY	43.81%
2019	-1.77 Billion CNY	69.21%
2018	-5.77 Billion CNY	-926.38%
2017	-562.31 Million CNY	-11.53%
2016	-504.2 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q1	-196.31 Million CNY	55.82%
2024 Q2	-196.31 Million CNY	0.0%
2023 Q3	-444.38 Million CNY	-538.71%
2023 Q1	-69.57 Million CNY	88.68%
2023 Q2	-69.57 Million CNY	0.0%
2023 Q4	-444.38 Million CNY	0.0%
2023 FY	-1.02 Billion CNY	52.83%
2022 Q2	-475.23 Million CNY	0.0%
2022 Q4	-614.4 Million CNY	0.0%
2022 FY	-2.17 Billion CNY	30.55%
2022 Q3	-614.4 Million CNY	-29.28%
2022 Q1	-475.23 Million CNY	44.91%
2021 Q4	-862.59 Million CNY	0.0%
2021 Q3	-862.59 Million CNY	-71.91%
2021 Q2	-501.77 Million CNY	0.0%
2021 Q1	-501.77 Million CNY	-157.17%
2021 FY	-3.13 Billion CNY	-214.3%
2020 FY	-998.42 Million CNY	43.81%
2020 Q4	-195.11 Million CNY	0.0%
2020 Q3	-195.11 Million CNY	35.84%
2020 Q2	-304.09 Million CNY	0.0%
2020 Q1	-304.09 Million CNY	39.52%
2019 FY	-1.77 Billion CNY	69.21%
2019 Q1	-357.2 Million CNY	87.72%
2019 Q3	-502.77 Million CNY	-40.75%
2019 Q4	-502.77 Million CNY	0.0%
2019 Q2	-357.2 Million CNY	0.0%
2018 Q1	21.94 Million CNY	112.35%
2018 Q4	-2.9 Billion CNY	0.0%
2018 Q3	-2.9 Billion CNY	-13348.7%
2018 Q2	21.94 Million CNY	0.0%
2018 FY	-5.77 Billion CNY	-926.38%
2017 Q1	-103.47 Million CNY	0.0%
2017 FY	-562.31 Million CNY	-11.53%
2017 Q4	-177.68 Million CNY	0.0%
2017 Q3	-177.68 Million CNY	-71.71%
2017 Q2	-103.47 Million CNY	0.0%
2016 FY	-504.2 Million CNY	0.0%

Peer Net Income Comparison of Innovent Biologics, Inc.

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	1550.298%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	6058.916%